Literature DB >> 29860660

RIT2: responsible and susceptible gene for neurological and psychiatric disorders.

Yousef Daneshmandpour1, Hossein Darvish2, Babak Emamalizadeh3.   

Abstract

RIT2 gene was recently introduced as a susceptibility gene in neurological disorders, a group of major problems in human society affecting millions of people worldwide. Several variants, including single nucleotide polymorphisms and CNVs, have been identified and studied in different populations. In this review, we have summarized the studies relevant to the RIT2 gene and its related disorders, including Parkinson's disease, schizophrenia, and autism. The protein product of RIT2 is a member of the Ras superfamily that plays important roles in many vital cellular functions, such as differentiation and survival. We have also investigated the protein network of the RIT2 protein and the diseases related to members of this network so as to obtain some clues for future studies by identifying the molecular pathophysiology of neurological disorders and revealing new possible disorders related to RIT2.

Entities:  

Keywords:  Autism; Bipolar disorder; Neurodegenerative disorder; Neurological disorder; Parkinson’s disease; RIT2; Ras; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29860660     DOI: 10.1007/s00438-018-1451-4

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  54 in total

1.  Ras-like without CAAX 2 (RIT2): a susceptibility gene for autism spectrum disorder.

Authors:  Shima Yazdandoost Hamedani; Jalal Gharesouran; Rezvan Noroozi; Arezou Sayad; Mir Davood Omrani; Atefeh Mir; Sarah Sadat Aghabozrg Afjeh; Mehdi Toghi; Saba Manoochehrabadi; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2017-02-11       Impact factor: 3.584

2.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 3.  Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor.

Authors:  Y Indo
Journal:  Hum Mutat       Date:  2001-12       Impact factor: 4.878

4.  A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V.

Authors:  H Houlden; R H King; A Hashemi-Nejad; N W Wood; C J Mathias; M Reilly; P K Thomas
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

5.  RIT2 rs12456492 polymorphism and the risk of Parkinson's disease: A meta-analysis.

Authors:  Xiaona Zhang; Mengyue Niu; Hong Li; Anmu Xie
Journal:  Neurosci Lett       Date:  2015-07-15       Impact factor: 3.046

6.  Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression.

Authors:  G Novak; P Seeman; T Tallerico
Journal:  Synapse       Date:  2006-01       Impact factor: 2.562

7.  RIT2 Polymorphisms: Is There a Differential Association?

Authors:  Babak Emamalizadeh; Javad Jamshidi; Abolfazl Movafagh; Mina Ohadi; Mahmoud Shekari Khaniani; Somayyeh Kazeminasab; Akbar Biglarian; Shaghayegh Taghavi; Marzieh Motallebi; Atena Fazeli; Azadeh Ahmadifard; Gholam-Ali Shahidi; Peyman Petramfar; Neda Shahmohammadibeni; Tahereh Dadkhah; Ehteram Khademi; Abbas Tafakhori; Ali Khaligh; Tannaz Safaralizadeh; Ali Kowsari; Arash Mirabzadeh; Amir Ehtesham Shafiei Zarneh; Mehdi Khorrami; Parasto Shokraeian; Mohammad Javad Soltani Banavandi; Behnam Safarpour Lima; Monavvar Andarva; Elham Alehabib; Minoo Atakhorrami; Hossein Darvish
Journal:  Mol Neurobiol       Date:  2016-03-03       Impact factor: 5.590

8.  Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Authors:  Nathan Pankratz; Gary W Beecham; Anita L DeStefano; Ted M Dawson; Kimberly F Doheny; Stewart A Factor; Taye H Hamza; Albert Y Hung; Bradley T Hyman; Adrian J Ivinson; Dmitri Krainc; Jeanne C Latourelle; Lorraine N Clark; Karen Marder; Eden R Martin; Richard Mayeux; Owen A Ross; Clemens R Scherzer; David K Simon; Caroline Tanner; Jeffery M Vance; Zbigniew K Wszolek; Cyrus P Zabetian; Richard H Myers; Haydeh Payami; William K Scott; Tatiana Foroud
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

9.  Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis.

Authors:  Caroline Charpin; Marielle Martin; Nathalie Balandraud; Jean Roudier; Isabelle Auger
Journal:  Arthritis Res Ther       Date:  2010-10-18       Impact factor: 5.156

10.  Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients.

Authors:  Sang Jae Noh; Jun Sang Bae; Urangoo Jamiyandorj; Ho Sung Park; Keun Sang Kwon; Sung Hoo Jung; Hyun Jo Youn; Ho Lee; Byung-Hyun Park; Myoung Ja Chung; Woo Sung Moon; Myoung Jae Kang; Kyu Yun Jang
Journal:  BMC Cancer       Date:  2013-11-01       Impact factor: 4.430

View more
  1 in total

Review 1.  The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases.

Authors:  Liang Qu; Chao Pan; Shi-Ming He; Bing Lang; Guo-Dong Gao; Xue-Lian Wang; Yuan Wang
Journal:  Front Mol Neurosci       Date:  2019-05-21       Impact factor: 5.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.